Serum Cotinine Level as Predictor of Lung Cancer Risk

Background: No prospective studies are available on serum cotinine level as a marker of lung cancer risk. Methods: We analyzed serum cotinine level among 1,741 individuals enrolled since the 1970s in a prospective study of Norwegian volunteers who developed lung cancer during the follow-up and 1,741 matched controls free from lung cancer. Serum cotinine was measured with a competitive immunoassay. Regression dilution was corrected for based on repeated measures on samples from 747 subjects. Results: Mean serum cotinine level was higher in cases than in controls. Compared with subjects with a cotinine level of ≤5 ng/mL, the odds ratio of lung cancer was increasing linearly, reaching 55.1 (95% confidence interval, 35.7-85.0) among individuals with a serum cotinine level of >378 ng/mL. There was no clear suggestion of a plateau in risk at high exposure levels. Odds ratios were very similar in men and women. We found no association between serum cotinine level (range, 0.1-9.9 ng/mL) and lung cancer risk among self-reported nonsmokers and long-term quitters (79 cases and 350 controls). Discussion: The association between tobacco smoking and lung cancer risk might be stronger than is estimated from questionnaire-based studies. Serum cotinine level is a predictor of risk of lung cancer among smokers. The reported plateau in risk at high doses is likely due mainly to artifacts. There is no difference between men and women in the carcinogenicity of tobacco smoking. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1184–8)

[1]  F. Clavel-Chapelon,et al.  Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study , 2005, BMJ : British Medical Journal.

[2]  M. Jarvis,et al.  Nicotine intake and dependence in Swedish snuff takers , 2005, Psychopharmacology.

[3]  Chris Bain,et al.  Lung cancer rates in men and women with comparable histories of smoking. , 2004, Journal of the National Cancer Institute.

[4]  J. Mclaughlin,et al.  Are women more susceptible to lung cancer? , 2004, Journal of the National Cancer Institute.

[5]  Peter B Bach,et al.  Lung cancer in US women: a contemporary epidemic. , 2004, JAMA.

[6]  David S Alberts,et al.  Accuracy of self-reported smoking status among participants in a chemoprevention trial. , 2004, Preventive medicine.

[7]  Michael J Thun,et al.  Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: results from Cancer Prevention Study II. , 2003, Cancer research.

[8]  Beatrice A Kallungal,et al.  Clinical considerations in study designs that use cotinine as a biomarker , 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[9]  J. Siegfried,et al.  Sex and gender differences in lung cancer. , 2003, The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia.

[10]  T Seppälä,et al.  Validation of self reported smoking by serum cotinine measurement in a community-based study , 2002, Journal of epidemiology and community health.

[11]  A. Haugen.  Women who smoke: are women more susceptible to tobacco-induced lung cancer? , 2002, Carcinogenesis.

[12]  G. Giovino,et al.  Factors associated with discrepancies between self-reports on cigarette smoking and measured serum cotinine levels among persons aged 17 years or older: Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, American journal of epidemiology.

[13]  M. Kogevinas,et al.  Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. , 2000, Mutation research.

[14]  P. Shields.  Epidemiology of tobacco carcinogenesis , 2000, Current oncology reports.

[15]  W. Ahrens,et al.  Gender differences in lung cancer risk by smoking: a multicentre case–control study in Germany and Italy , 1999, British Journal of Cancer.

[16]  R. Collins,et al.  Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.

[17]  M. Woodward,et al.  Self-reported smoking, cigarette yields and inhalation biochemistry related to the incidence of coronary heart disease: results from the Scottish Heart Health Study. , 1999, Journal of epidemiology and biostatistics.

[18]  M. Law,et al.  The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. , 1997, British Journal of Cancer.

[19]  N. Benowitz,et al.  Cotinine as a biomarker of environmental tobacco smoke exposure. , 1996, Epidemiologic reviews.

[20]  R. Collins,et al.  Cigarette smoking, tar yields, and non-fatal myocardial infarction : 14000 cases and 32000 controls in the United Kingdom , 1995 .

[21]  E. Riboli,et al.  Validity of urinary biomarkers of exposure to tobacco smoke following prolonged storage. , 1995, International journal of epidemiology.

[22]  M. Woodward,et al.  Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study. , 1995, Journal of epidemiology and community health.

[23]  E. Perez-stable,et al.  Is serum cotinine a better measure of cigarette smoking than self-report? , 1995, Preventive medicine.

[24]  Re Waller,et al.  Principles of Exposure Measurement in Epidemiology , 1994 .

[25]  M. Jarvis,et al.  Plasma cotinine: stability in smokers and validation of self-reported smoke exposure in nonsmokers. , 1994, Environmental research.

[26]  Diane C. Thompson,et al.  The validity of self-reported smoking: a review and meta-analysis. , 1994, American journal of public health.

[27]  A. Andersen,et al.  The JANUS serum bank. , 1993, The Science of the total environment.

[28]  E. Perez-stable,et al.  Misclassification of smoking status by self-reported cigarette consumption. , 1992, The American review of respiratory disease.

[29]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[30]  M. Woodward,et al.  Smoking characteristics and inhalation biochemistry in the Scottish population. , 1991, Journal of clinical epidemiology.

[31]  C. Feyerabend,et al.  A rapid gas‐liquid chromatographic method for the determination of cotinine and nicotine in biological fluids , 1990, The Journal of pharmacy and pharmacology.

[32]  J. Pierce,et al.  Cotinine validation of self-reported smoking in commercially run community surveys. , 1987, Journal of chronic diseases.

[33]  H. Tunstall-Pedoe,et al.  Biochemical markers of smoke absorption and self reported exposure to passive smoking. , 1984, Journal of epidemiology and community health.

[34]  J. Boreham,et al.  Inhaling and lung cancer: an anomaly explained. , 1983, British medical journal.

[35]  E. Wynder,et al.  Cigarette smoking: carboxyhemoglobin, plasma nicotine, cotinine and thiocyanate vs self-reported smoking data and cardiovascular disease. , 1983, Journal of chronic diseases.

[36]  R. Doll,et al.  Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. , 1978, Journal of epidemiology and community health.